Christine Gebski

Insider

First SEC filing: March 8, 2021 · Latest: March 8, 2021

On this page

Insider at Companies where this person is a reporting insider.
Insider transactions Every share this person bought or sold, from Form 4 filings.
Derivatives Options and other derivative holdings reported by this person.
Initial holdings The stakes this person held when they first started reporting.
Compensation Executive pay disclosed in company proxy statements.

Insider at

RGEN selling Nov. 10, 2023

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 22 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

22 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
May 14, 2024	RGEN	F	334	$163.34	$54,556	27,419 Direct	-1.20%	Disposed	8.1% (price as of 2026-08-21)
March 7, 2024	RGEN	F	386	$195.72	$75,548	27,753 Direct	-1.37%	Disposed	-9.7% (price as of 2026-08-21)
March 4, 2024	RGEN	F	131	$193.99	$25,413	28,139 Direct	-0.46%	Disposed	-8.9% (price as of 2026-08-21)
March 4, 2024	RGEN	F	461	$192.71	$88,839	28,270 Direct	-1.60%	Disposed	-8.3% (price as of 2026-08-21)
March 1, 2024	RGEN	F	447	$191.79	$85,730	28,731 Direct	-1.53%	Disposed	-7.9% (price as of 2026-08-21)
Feb. 29, 2024	RGEN	A	391	—	—	29,178 Direct	+1.36%	Acquired	(price as of 2026-08-21)
Nov. 10, 2023	RGEN	S	3,788	$147.13	$557,328	28,787 Direct	-11.63%	Disposed	20.1% (price as of 2026-08-21)
May 16, 2023	RGEN	F	334	$154.03	$51,446	32,575 Direct	-1.01%	Disposed	14.7% (price as of 2026-08-21)
March 3, 2023	RGEN	F	126	$188.00	$23,688	32,909 Direct	-0.38%	Disposed	-6.0% (price as of 2026-08-21)
March 3, 2023	RGEN	A	375	—	—	33,035 Direct	+1.15%	Acquired	(price as of 2026-08-21)
March 2, 2023	RGEN	A	3,590	—	—	3,590 Direct	—	Acquired	(price as of 2026-08-21)
March 2, 2023	RGEN	A	3,467	—	—	32,660 Direct	+11.88%	Acquired	(price as of 2026-08-21)
March 2, 2023	RGEN	F	630	$174.37	$109,853	29,193 Direct	-2.11%	Disposed	1.3% (price as of 2026-08-21)
Feb. 28, 2023	RGEN	F	460	$173.28	$79,709	29,823 Direct	-1.52%	Disposed	1.9% (price as of 2026-08-21)
Feb. 28, 2023	RGEN	F	452	$173.44	$78,395	30,283 Direct	-1.47%	Disposed	1.8% (price as of 2026-08-21)
Aug. 4, 2022	RGEN	S	3,357	$243.01	$815,785	30,735 Direct	-9.85%	Disposed	-27.3% (price as of 2026-08-21)
May 13, 2022	RGEN	F	335	$150.40	$50,384	34,092 Direct	-0.97%	Disposed	17.4% (price as of 2026-08-21)
Feb. 28, 2022	RGEN	F	598	$196.70	$117,627	34,427 Direct	-1.71%	Disposed	-10.2% (price as of 2026-08-21)
Feb. 27, 2022	RGEN	F	462	$196.70	$90,875	35,025 Direct	-1.30%	Disposed	-10.2% (price as of 2026-08-21)
Feb. 24, 2022	RGEN	A	2,721	—	—	2,721 Direct	—	Acquired	(price as of 2026-08-21)
Feb. 24, 2022	RGEN	F	181	$189.21	$34,247	35,487 Direct	-0.51%	Disposed	-6.6% (price as of 2026-08-21)
Feb. 24, 2022	RGEN	A	2,124	—	—	35,668 Direct	+6.33%	Acquired	(price as of 2026-08-21)
Feb. 17, 2022	RGEN	F	224	$182.42	$40,862	33,544 Direct	-0.66%	Disposed	-3.2% (price as of 2026-08-21)
Feb. 17, 2022	RGEN	A	450	—	—	33,768 Direct	+1.35%	Acquired	(price as of 2026-08-21)
Sept. 1, 2021	RGEN	S	3,377	$285.33	$963,559	33,318 Direct	-9.20%	Disposed	-38.1% (price as of 2026-08-21)
May 14, 2021	RGEN	S	445	$172.25	$76,651	36,695 Direct	-1.20%	Disposed	2.5% (price as of 2026-08-21)
March 16, 2021	RGEN	S	1,400	$196.88	$275,632	37,140 Direct	-3.63%	Disposed	-10.3% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
March 2, 2023	RGEN	Stock Option (Right to Buy)	Common Stock (3,590)	$180.48	March 2, 2033	3,590	Acquired
Feb. 24, 2022	RGEN	Stock Option (Right to Buy)	Common Stock (2,721)	$189.21	Feb. 24, 2032	2,721	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 6 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
March 8, 2021	RGEN	Common Stock	36,910	Direct
March 8, 2021	RGEN	Common Stock	1,630	Direct
March 8, 2021	RGEN	Stock Option (Right to Buy)→ Common Stock (10,000)	10,000	Direct
March 8, 2021	RGEN	Stock Option (Right to Buy)→ Common Stock (2,196)	2,196	Direct
March 8, 2021	RGEN	Stock Option (Right to Buy)→ Common Stock (3,391)	3,391	Direct
March 8, 2021	RGEN	Stock Option (Right to Buy)→ Common Stock (1,968)	1,968	Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

RGEN

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2021	$351,450	—	—	—	$328,606	—	$5,000	$1,671,749

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.